56916-81-5

Upstream product

• 56962-12-0 3-hydroxy-4-chlorobenzaldehyde 
• 100-39-0 benzyl bromide 
• 1252762-51-8 (3-(benzyloxy)-4-chlorophenyl)methanol 

Downstream Products

• 903578-38-1 4-(2-nitrovinyl)-1-chloro-2-(phenylmethoxy)benzene 
• 1252762-51-8 (3-(benzyloxy)-4-chlorophenyl)methanol 
• 903578-40-5 (R)-4-(3-(benzyloxy)-4-chlorophenyl)pyrrolidin-2-one 
• 1252763-01-1 (R)-4-amino-3-(4-chloro-3-(pyridin-4-ylmethoxy)phenyl)butanoic acid 

Relevant academic research and scientific papers

Synthesis and Evaluation of a New 18F-Labeled Radiotracer for Studying the GABAB Receptor in the Mouse Brain

New GABAB agonists, fluoropyridyl ether analogues of baclofen, have been synthesized as potential PET radiotracers. The compound with highest inhibition binding affinity as well as greatest agonist response, (R)-4-amino-3-(4-chloro-3-((2-fluoro

DIHYDROQUINOLIZINONES AS ANTIVIRALS

Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds. Formula (I):

GAMMA-AMINO-BUTYRIC ACID DERIVATIVES AS GABAB RECEPTOR LIGANDS

Gamma-amino-butyric acid derivatives that are GABAB receptor ligands, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives and pharmaceutical compositions thereof for treating diseases are disclosed.

PHENYL-SUBSTITUTED PYRROLIDONES

The present invention relates to phenyl-substituted pyrrolidones and compounds related to phenyl-substituted pyrrolidones. One use of these compounds is for the inhibition of viruses, e.g., HIV. The invention further relates to methods of malting these compounds, methods of identifying the efficacy of these compounds, and methods of using these compounds to inhibit or prevent HIV infection and related disease states such as AIDS.